Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Carcinoma × temoporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Carcinoma, Large Cell 1 Adenocarcinoma 1

Interventions

Cisplatin 121 Gemcitabine 67 Radiotherapy, Intensity-Modulated 58 Docetaxel 36 toripalimab 34 Fluorouracil 34 Capecitabine 34 Radiotherapy 21 Drug Therapy 20 camrelizumab 19 nimotuzumab 18 spartalizumab 12 pembrolizumab 12 nedaplatin 12 apatinib 11 Induction Chemotherapy 11 sintilimab 10 Chemoradiotherapy 10 tislelizumab 9 Magnetic Resonance Spectroscopy 9 Carboplatin 9 Specimen Handling 8 Radiation 8 Nivolumab 8 Cetuximab 8 Bevacizumab 8 endostar protein 7 Paclitaxel 7 Immune Checkpoint Inhibitors 7 Endostatins 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡